Similar articles

• Editorial comment.

  Pastuszak AW. Pastuszak AW. J Urol. 2015 Feb;193(2):414. doi: 10.1016/j.juro.2014.07.130. Epub 2014 Oct 30. J Urol. 2015. PMID: 25534589 No abstract available.
• Serum Testosterone Levels and Prostate Cancer Risk: A Single Post-Hoc Testosterone Measurement is Not Informative.

  Loughlin KR. Loughlin KR. J Urol. 2019 Jan;201(1):40-41. doi: 10.1016/j.juro.2018.08.042. J Urol. 2019. PMID: 30130546 No abstract available.
• Editorial comment.

  Prasad SM, Keane TE, Bennett CL. Prasad SM, et al. Urology. 2012 Jul;80(1):168. doi: 10.1016/j.urology.2012.01.069. Epub 2012 May 18. Urology. 2012. PMID: 22608794 No abstract available.
• Editorial comment.

  Nelson PS. Nelson PS. Urology. 2012 Jul;80(1):180-1; author reply 181. doi: 10.1016/j.urology.2012.01.093. Urology. 2012. PMID: 22748874 No abstract available.
• The relationship between total testosterone levels and prostate cancer: a review of the continuing controversy.

  Klap J, Schmid M, Loughlin KR. Klap J, et al. J Urol. 2015 Feb;193(2):403-13. doi: 10.1016/j.juro.2014.07.123. Epub 2014 Sep 28. J Urol. 2015. PMID: 25260832 Review.